Table 1.
Baseline demographic and clinical characteristics of participants admitted in 2019 and 2020.
Parameter | 2019 (n = 105) | 2020 (n = 120) | P |
---|---|---|---|
Age, years | 69.0 (62.0, 77.0) | 65.0 (58.0, 74.0) | 0.024 |
Male/Female | 57/48 | 83/37 | 0.031 |
Diabetes duration, years | 19.3 ± 10.9 | 21.3 ± 12.6 | 0.196 |
HbA1c, % | 7.3 (6.7, 8.5) | 7.8 (6.8, 9.0) | 0.168 |
HbA1c, mmol/mol | 56 (50, 69) | 62 (51, 75) | |
Renal Fuction | |||
Creatinine, mg/dl | 1.0 (0.8, 1.3) | 1.0 (0.8, 1.4) | 0.629 |
eGFR, ml/min | 68.8 ± 29.7 | 67.1 ± 26.9 | 0.664 |
UACR, mg/g Cr | 20.5 (5.5, 80.0) | 51.5 (25.0, 165.0) | <0.001 |
CRP, mg/dl | 0.9 (0.3, 3.0) | 2.1 (0.8, 5.9) | <0.001 |
WBC, nx10e3/ul | 8.3 (6.3, 10.0) | 9.6 (7.5, 11.7) | <0.001 |
Peripheral Artery Disease, n (%) | 76 (72) | 90 (75) | 0.796 |
Peripheral Neuropathy, n (%) | 78 (74) | 102 (85) | 0.066 |
History of previous ulcer, n (%) | 53 (50) | 84 (70) | 0.004 |
Ulcer duration, months | 5.0 (2.0, 12.0) | 4.0 (2.0, 8.0) | 0.195 |
Outpatient patients, n (%) | 41 (39) | 31 (25) | 0.048 |
Admitted in emergency, n (%) | 39 (37) | 72 (60) | 0.001 |
TEXAS classification system, n (%) | |||
Superficial wound | 27 (26) | 21 (18) | 0.181 |
Affecting tendons/capsules | 25 (24) | 25 (21) | 0.708 |
Affecting bone/joint | 53 (50) | 74 (62) | 0.120 |
Osteomyelitis, n (%) | 53 (50) | 74 (62) | 0.120 |
Gangrene, n (%) | 14 (13) | 46 (38) | <0.001 |
Revascularization, n (%) | 14 (13) | 28 (23) | 0.080 |
Amputation, n (%) | 26 (25) | 48 (40) | 0.022 |
Data are reported as mean ± SD, median (IQR) or number and percentage. CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; UACR, urinary albumin to creatinine ratio; WBC, white blood cells.